A PYMNTS Company

US: Pharmaceutical cos ink $640 buyout deal

By  |  August 31, 2013

Hi-Tech Pharmaceutical Co. announced Friday plans to be acquired by competitor Akorn, Inc. in a deal worth $640 million.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    According to a press release, the combined company anticipates about $500 million in annual revenue.

    In a statement, Akorn CEO Raj Rai described the deal as “a transformative event” for the company. Both companies operate their particular specialties within the pharmaceutical industry.

    The dealremains subject to approval by antitrust regulators.

    Full Content: Pharma Live

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.